Phase III-IV ALK+ ALCL
1 clinical trials · Condition
◉ Watch Phase III-IV ALK+ ALCL
| Record | Firm | Date |
|---|---|---|
| Lenalidomide in Combination With CHOP in Patients With Untreated PTCL (NCT04423926) | The First Affiliated Hospital with Nanjing Medical University | 2020-06-10 |
Track Phase III-IV ALK+ ALCL automatically
Every clearance here is in the API, with alerts when new ones post.